Results 101 to 110 of about 20,432 (139)

Impact of Dolutegravir-, Lopinavir/Ritonavir-, and Efavirenz-Based Antiretrovirals on Piperaquine Pharmacokinetics in Ugandan Children Living with HIV. [PDF]

Clin Pharmacol Ther
Kajubi R, Koire M, Whalen ME, Orukan F, Okiring J, Marzan F, Richards K, Lier AJ, Goodwin J, Colt M, Pham X, He S, Chu DHT, Opira B, Kisitu GP, Sekabira R, Kekitiinwa A, Huynh D, Khoury M, Gallison K, Fotaki N, Mwima MW, Kamya MR, Aweeka FT, Parikh S, Huang L, Mwebaza N.   +26 more
europepmc   +1 more source

Efavirenz and CYP2C9 Genetic Polymorphisms Reduce CYP2C9 Activity in Healthy Participants. [PDF]

Clin Transl Sci
Kim JD, Metzger IF, Lu JBL, Skaar TC, Desta Z.   +4 more
europepmc   +1 more source

Risk of Major Adverse Cardiovascular Events With Dolutegravir Versus Efavirenz-Based Antiretroviral Therapy: Emulated Target Trials Using Routine, De-identified Data From South Africa. [PDF]

Clin Infect Dis
Dorward J, Masombuka X, Lewis L, Pastellides C, van der Molen J, Asare K, Tlhaku K, Brown JA, Bottomley C, Jacobs D, Collie S, Garrett N.   +11 more
europepmc   +1 more source

Development and Validation of Bioanalytical Method for Efavirenz in Dried Blood Spot Using High Performance Liquid Chromatography-Photodiode Array. [PDF]

J Exp Pharmacol
Putri DN, Harahap Y, Saputri FA.
europepmc   +1 more source

Efavirenz metabolism and CNS toxicity in Ugandan children: impact of CYP2B6 genotype and plasma metabolite profiles. [PDF]

Front Pharmacol
Soeria-Atmadja S, Pettersson Bergstrand M, Amuge P, Nanzigu S, Bbuye D, Rubin J, Kekitiinwa A, Obua C, Dahl ML, Pohanka A, Gustafsson LL, Navér L, Eriksen J.   +12 more
europepmc   +1 more source

Late-Onset Efavirenz-Induced Liver Toxicity in a 17-Year-Old, Filipino, Patient With HIV. [PDF]

ACG Case Rep J
Clutario JDC, Chan SNL, Pedregosa GS, Labio MED, Caoili JC, Mendoza RD.   +5 more
europepmc   +1 more source

Brief Report: Earlier Referral to Differentiated Antiretroviral Therapy Delivery at Six Months After Initiation: A Retrospective Cohort Study in KwaZulu-Natal, South Africa. [PDF]

J Acquir Immune Defic Syndr
van der Molen JS, Tlhaku K, Lewis L, Sookrajh Y, Hobe L, Ngwenya T, Khanyile M, Khubone T, Garrett N, Brown JA, Dorward J.   +10 more
europepmc   +1 more source

Evaluating the Impact of Intestinal Bile Salts on Drug Absorption Using PBPK Modeling: Case Studies With Efavirenz, Cinnarizine, and Posaconazole. [PDF]

CPT Pharmacometrics Syst Pharmacol
Al-Amiry Santos LG, Polak S, Yeo KR.
europepmc   +1 more source

Hepatotoxicity Among People With HIV and Receiving Isoniazid Preventive Therapy in Pregnancy and Postpartum: The Role of Antiretroviral Regimen and Pharmacogenetics. [PDF]

Clin Infect Dis
Montepiedra G, Aaron L, Theron G, McCarthy K, Bradford S, Chipato T, Vhembo T, Stranix-Chibanda L, Wabwire D, Masheto G, Jean-Philippe P, Sterling TR, Weinberg A, Gupta A, IMPAACT P1078 TB APPRISE Study Team.   +14 more
europepmc   +1 more source